Foreword |
|
xxv | |
|
Preface |
|
xxvii | |
Introduction |
|
1 | (100) |
Part I Cancer |
|
101 | |
|
|
11 | (16) |
|
Chapter 2 What Is Cancer? |
|
|
27 | (23) |
|
Chapter 3 Statistics-Misconceptions of Reality |
|
|
50 | (12) |
|
Chapter 4 Conventional Treatments and Testing |
|
|
62 | (21) |
|
Chapter 5 Chemosensitivity, Genomic, and Natural-Agent Sensitivity Testing Overview |
|
|
83 | (8) |
Part II Tests |
|
|
|
91 | (5) |
|
|
91 | (1) |
|
|
91 | (1) |
|
|
92 | (1) |
|
|
92 | (1) |
|
|
92 | (1) |
|
|
92 | (1) |
|
|
93 | (1) |
|
|
93 | (2) |
|
|
95 | (1) |
|
Chapter 7 Biocept-Circulating Tumor Cell Count and Biomarker Identification |
|
|
96 | (5) |
|
|
96 | (1) |
|
|
97 | (1) |
|
|
97 | (1) |
|
|
97 | (1) |
|
|
97 | (1) |
|
|
98 | (1) |
|
|
98 | (1) |
|
|
98 | (1) |
|
|
98 | (1) |
|
|
99 | (2) |
|
|
101 | (3) |
|
|
101 | (1) |
|
|
101 | (1) |
|
|
101 | (1) |
|
|
102 | (1) |
|
|
102 | (1) |
|
|
102 | (1) |
|
|
102 | (1) |
|
|
102 | (1) |
|
|
102 | (1) |
|
|
103 | (1) |
|
Chapter 9 The Cancer Profile© |
|
|
104 | (6) |
|
|
104 | (1) |
|
|
105 | (1) |
|
|
106 | (1) |
|
|
106 | (1) |
|
|
106 | (1) |
|
|
107 | (1) |
|
|
107 | (1) |
|
|
107 | (1) |
|
|
108 | (2) |
|
Chapter 10 Cologuard®-Stool DNA Home Screening Kit |
|
|
110 | (4) |
|
|
110 | (1) |
|
|
110 | (1) |
|
|
111 | (1) |
|
|
111 | (1) |
|
|
111 | (1) |
|
|
112 | (1) |
|
|
112 | (1) |
|
|
112 | (1) |
|
|
113 | (1) |
|
Chapter 11 Colon Health Screening for Occult Blood in Stool-Home Test Kit |
|
|
114 | (3) |
|
|
114 | (1) |
|
|
115 | (1) |
|
|
115 | (1) |
|
|
115 | (1) |
|
|
115 | (1) |
|
|
115 | (1) |
|
|
115 | (1) |
|
|
116 | (1) |
|
|
116 | (1) |
|
|
117 | (3) |
|
|
117 | (1) |
|
|
117 | (1) |
|
|
117 | (1) |
|
|
117 | (1) |
|
|
117 | (1) |
|
|
118 | (1) |
|
|
118 | (1) |
|
|
118 | (1) |
|
|
118 | (1) |
|
|
119 | (1) |
|
Chapter 13 EarlyCDT-Lung Test |
|
|
120 | (5) |
|
|
120 | (1) |
|
|
120 | (1) |
|
|
121 | (1) |
|
|
121 | (1) |
|
|
121 | (1) |
|
|
122 | (1) |
|
|
122 | (1) |
|
|
122 | (1) |
|
|
122 | (1) |
|
|
123 | (2) |
|
Chapter 14 Human Chorionic Gonadotropin (HCG) Test |
|
|
125 | (6) |
|
|
125 | (1) |
|
|
126 | (1) |
|
|
127 | (1) |
|
|
127 | (1) |
|
|
127 | (1) |
|
|
128 | (1) |
|
|
128 | (1) |
|
|
128 | (1) |
|
|
128 | (2) |
|
|
130 | (1) |
|
|
131 | (3) |
|
|
131 | (1) |
|
|
131 | (1) |
|
|
131 | (1) |
|
|
132 | (1) |
|
|
132 | (1) |
|
|
132 | (1) |
|
|
132 | (1) |
|
|
132 | (20) |
|
|
152 | |
|
|
133 | (1) |
|
|
134 | (4) |
|
|
134 | (2) |
|
|
136 | (1) |
|
|
136 | (1) |
|
|
136 | (1) |
|
|
136 | (1) |
|
|
136 | (1) |
|
|
137 | (1) |
|
|
137 | (1) |
|
Chapter 17 OralID-Oral Cancer Screening |
|
|
138 | (2) |
|
|
138 | (1) |
|
|
138 | (1) |
|
|
138 | (1) |
|
|
139 | (1) |
|
|
139 | (1) |
|
|
139 | (1) |
|
|
139 | (1) |
|
|
139 | (1) |
|
|
139 | (1) |
|
Chapter 18 Papanicolaou (Pap) and Human Papillomavirus (HPV) |
|
|
140 | (5) |
|
|
140 | (1) |
|
|
141 | (1) |
|
|
142 | (1) |
|
|
143 | (1) |
|
|
143 | (1) |
|
|
143 | (1) |
|
|
143 | (1) |
|
|
144 | (1) |
|
|
144 | (1) |
|
Chapter 19 Prostate Health Index |
|
|
145 | (3) |
|
|
145 | (1) |
|
|
146 | (1) |
|
|
146 | (1) |
|
|
146 | (1) |
|
|
146 | (1) |
|
|
146 | (1) |
|
|
146 | (1) |
|
|
146 | (1) |
|
|
147 | (1) |
|
|
147 | (1) |
|
Chapter 20 Research Genetic Cancer Center Lab Tests |
|
|
148 | (21) |
|
|
148 | (9) |
|
|
157 | (1) |
|
|
157 | (1) |
|
|
158 | (4) |
|
|
162 | (1) |
|
|
163 | (1) |
|
|
163 | (1) |
|
|
164 | (1) |
|
|
165 | (2) |
|
|
167 | (2) |
|
Chapter 21 Thymidine Kinase Test |
|
|
169 | (2) |
|
|
169 | (1) |
|
|
169 | (1) |
|
|
170 | (1) |
|
|
170 | (1) |
|
|
170 | (1) |
|
Chapter 22 Videssa® Breast Test |
|
|
171 | (3) |
|
|
171 | (1) |
|
|
171 | (1) |
|
|
172 | (1) |
|
|
172 | (1) |
|
|
172 | (1) |
|
|
172 | (1) |
|
|
172 | (1) |
|
|
173 | (1) |
|
|
173 | (1) |
|
Chapter 23 Biofocus® Tests |
|
|
174 | (2) |
|
|
174 | (1) |
|
|
175 | (1) |
|
|
175 | (1) |
|
|
175 | (1) |
|
Chapter 24 CELLSEARC®-Circulating Tumor Cell Count Test |
|
|
176 | (3) |
|
|
176 | (1) |
|
|
176 | (1) |
|
|
177 | (1) |
|
|
177 | (1) |
|
|
177 | (1) |
|
|
177 | (1) |
|
|
177 | (2) |
|
Chapter 25 Canis Molecular Intelligence®-Genomic Profile |
|
|
179 | (4) |
|
|
179 | (1) |
|
|
179 | (1) |
|
|
179 | (1) |
|
|
180 | (1) |
|
|
180 | (1) |
|
|
180 | (1) |
|
|
180 | (1) |
|
|
181 | (1) |
|
|
181 | (1) |
|
|
182 | (1) |
|
Chapter 26 FoundationOne®-Comprehensive Genomic Profile |
|
|
183 | (6) |
|
|
183 | (1) |
|
|
184 | (1) |
|
|
185 | (1) |
|
|
185 | (1) |
|
|
185 | (1) |
|
|
185 | (1) |
|
|
185 | (1) |
|
|
186 | (1) |
|
|
186 | (1) |
|
|
187 | (2) |
|
Chapter 27 Nagourney Cancer Institute-Functional Profile Chemosensitivity and Targeted Agent Test |
|
|
189 | (6) |
|
|
189 | (1) |
|
|
190 | (1) |
|
|
191 | (1) |
|
|
192 | (1) |
|
|
192 | (1) |
|
|
192 | (1) |
|
|
192 | (2) |
|
|
194 | (1) |
|
Chapter 28 Additional Labs Offering Chemosensitivity Testing From Live Tissue Samples |
|
|
195 | (4) |
Part III Additional Information To Consider |
|
|
Chapter 29 Suggested Testing Uses |
|
|
199 | (3) |
|
Chapter 30 Connecting With an Integrative Physician |
|
|
202 | (3) |
|
Chapter 31 Functional Testing Overview |
|
|
205 | (6) |
|
Chapter 32 Low-Dose Approach to Chemotherapy |
|
|
211 | (8) |
|
Chapter 33 Cancer-Beat It, Don't Feed It |
|
|
219 | (8) |
|
|
227 | (34) |
|
|
261 | (6) |
Notes |
|
267 | (29) |
Index |
|
296 | |